Technology
University of Washington and Seattle biotech win $245M patent judgment against Guardant
A Seattle biotechnology company that originated from University of Washington research secured a $245 million patent judgment against Gua…
AI Summary
A Seattle biotechnology company that originated from University of Washington research secured a $245 million patent judgment against Guardant Health for alleged infringement of DNA sequencing technology. The court also mandated that Guardant pay ongoing royalties to the biotech through 2033.
Read full article on GeekwireAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Technology
Continue reading recent Technology coverage
- The best early Labor Day 2026 laptop deals: Apple, Lenovo, Dell, and moreContinue reading
- That fake Grand Theft Auto VI demo is actually just malwareContinue reading
- Waymo is expanding to Germany, with service in Munich planned for 2027Continue reading
- Apple M5 Ultra vs M3 Ultra: What's changed?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow